May 10, 2026 · JAMA · DOI: 10.1001/jama.2026.7886

Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis

Listen to this summary

The authors aimed to evaluate the efficacy and safety of digitalis glycosides in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or reduced ejection fraction (HFrEF). Their meta-analysis of three randomized controlled trials involving 9,013 patients found that digitalis glycosides significantly reduced the risk of cardiovascular death or first worsening heart failure event, primarily by lowering the incidence of worsening heart failure. These findings suggest that digitalis glycosides may be a beneficial adjunct therapy for managing these heart failure conditions.

Kevin Damman, Dirk J van Veldhuisen, Johann Bauersachs, Michiel Rienstra, Arend Mosterd, Adriaan A Voors, Geert H D Voordes, Udo Bavendiek, Peter van der Meer

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play